Annovis Total Liab from 2010 to 2025

ANVS Stock  USD 1.75  0.05  2.78%   
Annovis Bio Total Liabilities yearly trend continues to be comparatively stable with very little volatility. Total Liabilities is likely to outpace its year average in 2025. Total Liabilities is the total amount of all liabilities that Annovis Bio has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2012-12-31
Previous Quarter
6.8 M
Current Value
7.3 M
Quarterly Volatility
4.5 M
 
Yuan Drop
 
Covid
Check Annovis Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Annovis Bio's main balance sheet or income statement drivers, such as Interest Expense of 199.6 K, Selling General Administrative of 7.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0069. Annovis financial statements analysis is a perfect complement when working with Annovis Bio Valuation or Volatility modules.
  
Check out the analysis of Annovis Bio Correlation against competitors.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis Bio guide.

Latest Annovis Bio's Total Liab Growth Pattern

Below is the plot of the Total Liab of Annovis Bio over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Annovis Bio's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Annovis Bio's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Annovis Total Liab Regression Statistics

Arithmetic Mean8,209,051
Geometric Mean4,024,493
Coefficient Of Variation81.65
Mean Deviation4,644,377
Median7,323,523
Standard Deviation6,702,460
Sample Variance44.9T
Range21.6M
R-Value0.66
Mean Square Error27.1T
R-Squared0.44
Significance0.01
Slope930,799
Total Sum of Squares673.8T

Annovis Total Liab History

202521.7 M
202420.7 M
202318 M
20227.7 M
20211.5 M
2020578.4 K
20199.7 M

About Annovis Bio Financial Statements

Annovis Bio shareholders use historical fundamental indicators, such as Total Liab, to determine how well the company is positioned to perform in the future. Although Annovis Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Annovis Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Annovis Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities20.7 M21.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Annovis Stock Analysis

When running Annovis Bio's price analysis, check to measure Annovis Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis Bio is operating at the current time. Most of Annovis Bio's value examination focuses on studying past and present price action to predict the probability of Annovis Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis Bio's price. Additionally, you may evaluate how the addition of Annovis Bio to your portfolios can decrease your overall portfolio volatility.